Evidence map›Paper›PMID 41472960›Full record

Trial reportInternational journal of chronic obstructive pulmonary disease2025

Effects of Individualized Step Targets on Physical Activity in COPD. A Randomized Study.

Yoshiaki Minakata, Seigo Sasaki, Yusuke Murakami, Kazumi Kawabe, Hideya Ono, Koichiro Takahashi, Kazuhisa Asai, Masanori Nakanishi, Tsunahiko Hirano, Kazuto Matsunaga

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yoshiaki MinakataDepartment of Respiratory Medicine, NHO Wakayama Hospital, Hidaka-gun, Wakayama, Japan.ORCID 0000-0001-6993-0917
Seigo SasakiDepartment of Respiratory Medicine, NHO Wakayama Hospital, Hidaka-gun, Wakayama, Japan.
Yusuke MurakamiDepartment of Respiratory Medicine, NHO Wakayama Hospital, Hidaka-gun, Wakayama, Japan.
Kazumi KawabeDepartment of Respiratory Medicine, NHO Wakayama Hospital, Hidaka-gun, Wakayama, Japan.
Hideya OnoDepartment of Respiratory Medicine, NHO Wakayama Hospital, Hidaka-gun, Wakayama, Japan.
Koichiro TakahashiDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.ORCID 0000-0003-0461-5072
Kazuhisa AsaiDepartment of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.ORCID 0000-0001-8400-863X
Masanori NakanishiThird Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Tsunahiko HiranoDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.ORCID 0000-0002-5475-0806
Kazuto MatsunagaDepartment of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.ORCID 0000-0002-0514-3241

Funding

Environmental Restoration and Conservation Agency, Japan
6 · The paper itself

Abstract

Purpose: Improving physical activity (PA) is important in patients with chronic obstructive pulmonary disease (COPD). Goal setting can be a possible intervention to improve PA, but the increase in PA is not sustainable in the long term. We evaluated the effects of providing an individualized target step count, reflecting the disease condition of each patient, on PA and other factors, such as myokines, after six months in patients with COPD. Patients and Methods: We performed a randomized parallel group, open-label study (INTAR-Step study) between the target provision (intervention) group and the usual care (control) group and investigated differences in the proportion of subjects who achieved the target as a primary outcome and differences in changes in PA parameters and myokines as secondary outcomes. This study was registered with UMIN-CTR (UMIN000046390, January 13, 2022). Results: A total of 73 subjects were analyzed (intervention, n=38; control, n=35). The proportion of participants in the intervention group who achieved their target step count did not show a significant increase relative to the control group (p=0.157). However, the change in step count, and change in duration of activity at ≥3.0 metabolic equivalents were significantly increased in the intervention group. The Changes in the Growth differentiation factor-15 (GDF-15), fatty acid-binding protein-3, and Irisin levels also increased in the intervention group. Furthermore, GDF-15 levels were significantly higher in subjects with increased step counts than in those with decreased step counts. Conclusion: Providing individualized step targets did not increase the proportion of subjects who achieved their targets, but it increased their step counts after six months. GDF-15 may be involved in the increase in the step count.

Indexed as

ExerciseExercise TherapyLungPulmonary Disease, Chronic ObstructiveAgedBiomarkersExercise ToleranceFemaleFibronectinsGrowth Differentiation Factor 15HumansMaleMiddle AgedTime FactorsTreatment OutcomeBiomarkersFibronectinsFNDC5 protein, humanGDF15 protein, humanGrowth Differentiation Factor 15accelerometerbehavior modificationGDF-15goal settingmyokine

Identifiers

PMID41472960
PMCPMC12746748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.